Summit Investment Advisors »

Recursion Pharmaceuticals shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $134k 14k 9.86
2023-09-30 $104k 14k 7.65
2023-06-30 $84k 11k 7.47
2023-03-31 $68k 10k 6.67
2022-12-31 $88k 10k 8.71
2022-09-30 $107k 10k 10.55
2022-06-30 $82k 10k 8.09
2022-03-31 $64k 8.9k 7.18
2021-12-31 $153k 8.9k 17.18
2021-09-30 $50k 2.2k 23.18
2021-06-30 $60k 1.7k 36.21